Abstract:Purpose: Recent animal studies suggest that activation of Wnt/β-catenin signaling in articular chondrocytes might be a driving factor in the pathogenesis of osteoarthritis (OA) by stimulating amongst others the expression of matrix metalloproteinases (MMPs). Indeed in animal chondrocytes IL-1β induced MMP expression is mediated by activation of canonical Wnt/β-catenin signaling. This study aimed to investigate the role of Wnt/β-catenin signaling in IL-1β induced MMP expression in human chondrocytes. Methods: Primary cultures of human articular chondrocytes derived from post mortem healthy donors or patients with end stage osteoarthritis or rheumatoid arthritis were used in all experiments. Cells were stimulated with recombinant growth factors and cytokines. Changes in gene and protein expression were studied using qPCR, Western blot, and enzymatic essays. Multiple strategies for activation and inhibition of signaling pathways in human chondrocytes, such as lentiviral mediated gene overexpression or gene knock down were used. Luciferase reporter assays and co-immunoprecipitation essays were used to study the interaction between β-catenin and NF-κB. Results: IL-1β potently stimulated MMP1, -3 and -13 expression in human and murine chondrocytes dose-dependently. In marked contrast, co-stimulation with the recombinant Wnt3A, which activates canonical Wnt/β-catenin signaling, potently inhibited IL-1β induced MMP dose-dependently in human chondrocytes but not in murine chondrocytes. This inhibitory effect was found in human chondrocytes irrespective of the disease state of the donor being either healthy, osteoarthritic or rheumatoid arthritic and was also found in human bone marrow derived mesenchymal stem cells. In contrast, Wnt/β-catenin signaling induced MMP expression in chondrocytes of all animal species tested, revealing an unprecedented species difference. Wnt3A's inhibitory effect was found in both basal conditions and after IL-1β stimulation at the mRNA level, protein level and in enzymatic essays. Wesetern blot indicated that IL-1β indirectly activated β-catenin in human chondrocytes. This was due to IL-1β induced upregulation of the canonical Wnt7B and down regulation of the Wnt-signaling antagonists DKK1, Wif1 and FRZb as demonstrated by gene knock down and gene overexpression studies. The inhibitory effect of Wnt3A on IL-1β induced MMP expression was independent of TCF/LEF transcription factors, since knock down of TCF4 did not alter Wnt3A's effect. This was in marked contrast to murine chondrocytes in which knock down of TCF4 completely blocked IL-1β induced MMP expression. Subsequently, we showed that the inhibitory effect on IL-1β induced MMP expression in human chondrocytes was due to an inhibitory protein-protein interaction between β-catenin and NF-κB/p65RELA blocking the activation of NF-κB promoter reporter constructs as well as inhibiting the expression of established NF-κB target genes like IL-6. Conclusions: Our study reveals an unexpected and unprecedented species difference between human and animal chondrocytes with respect of the role of Wnt/β-catenin signaling in the regulation of MMP expression. In marked contrast to mouse chondrocytes in which Wnt/β-catenin signaling is part of an IL-1β activated pro-catabolic sequence resulting in increased MMP expression, in human cells β-catenin has an unexpected anti-catabolic role. We provide evidence that Wnt/β-catenin signaling is part of an IL-1β activated negative feedback loop involving upregulation of the canonical Wnt7B and down regulation of established Wnt-antagonists like DKK1. This leads to activation of β-catenin, which in turn inhibits NF-κB activity due to an inhibitory protein-protein interaction with p65RELA. Our results question the relevance of animal models for studying the role of Wnt/β-catenin signaling in osteoarthritis. They furthermore imply that upregulated β-catenin in human osteoarthritic cartilage may be part of an anti-catabolic response counteracting pro-catabolic NF-κB signaling.

Wnt5a manipulate the progression of osteoarthritis via MMP-13 dependent signaling pathway

Activation of the P38/CREB/MMP 13 Axis is Associated with Osteoarthritis

Wnt3a knockdown promotes collagen type II expression in rat chondrocytes

Wnt/ Beta -Catenin Signaling in the Pathogenesis of Osteoarthritis

Wnt/β‑catenin Signaling May Induce Senescence of Chondrocytes in Osteoarthritis

MicroRNA-1 Modulates Chondrocyte Phenotype by Regulating FZD7 of Wnt/ β-Catenin Signaling Pathway

Effect of the Interaction Between MiR-200b-3p and DNMT3A on Cartilage Cells of Osteoarthritis Patients.

Expression of Adamts-5 and Timp-3 in the Condylar Cartilage of Rats Induced by Experimentally Created Osteoarthritis

1,25-Dihydroxyvitamin D3 Activates MMP13 Gene Expression in Chondrocytes Through P38 MARK Pathway.

Role of Wnt-5A in interleukin-1beta-induced matrix metalloproteinase expression in rabbit temporomandibular joint condylar chondrocytes.

Downregulation of HS6ST2 by Mir-23B-3p Enhances Matrix Degradation Through P38 MAPK Pathway in Osteoarthritis

Regulation of Matrix Metalloproteinase-13 by MIRNA-320 in Chondrogenesis and Osteoarthritis

Downregulated Microrna‐106 Inhibits Apoptosis and Promotes Proliferation and Differentiation of Chondrocytes in Osteoarthritis Through Restraining the Activation of Wnt/β‐catenin Pathway

Circ_0136474 and MMP-13 Suppressed Cell Proliferation by Competitive Binding to Mir-127-5p in Osteoarthritis

A WNT/β-catenin Negative Feedback Loop Inhibits IL-1β Induced Mmp Expression in Human Articular Chondrocytes

Down-Regulation Of Microrna-145 Expression Promote Resistance To Chondrocyte Apoptosis In Osteoarthritis

Exosomes derived from miR-92a-3p-overexpressing human mesenchymal stem cells enhance chondrogenesis and suppress cartilage degradation via targeting WNT5A

The Wnt signaling cascade in the pathogenesis of osteoarthritis and related promising treatment strategies

Hypoxia-induced Wnt/-catenin signaling activation in subchondral bone osteoblasts leads to an osteoarthritis-like phenotype of chondrocytes in articular cartilage

Down-regulation of MiR-138-5p Protects Chondrocytes ATDC5 and CHON-001 from IL-1 Β-Induced Inflammation Via Up-regulating SOX9.

MicroRNA-320 Regulates Matrix Metalloproteinase-13 Expression in Chondrogenesis and Interleukin-1Β-induced Chondrocyte Responses